382 followers
Rubo la didascalia ad Adriano Aguzzi: "A provocative, well-written paper that challenges antibody therapy in... https://t.co/PdguLdHV32
Rubo la didascalia ad Adriano Aguzzi: "A provocative, well-written paper that challenges antibody therapy in... https://t.co/PdguLdHV32
Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials. - PubMed - https://t.co/et3DGEl3US